Riding the subway at rush hour, you accept a basic truth: the system wasn't designed to get you specifically where you need to go - it was built for the masses, and you just happen to fit the route. Colonoscopy screening works the same way. The schedule, the intervals, the recommended stops along the timeline of your life - they're built for the general population. But what happens when you're past the last official stop on the map, you're 75-plus, and the transit authority keeps telling you to stay on the train?
A new editorial in JAMA by gastroenterologists Christina Wang, Brijen Shah, and Steven Itzkowitz from Mount Sinai wants us to rethink the whole route for older riders (Wang et al., 2026).
The Hero Nobody Asked to Retire
Colonoscopy is, without question, one of the great protagonists of modern preventive medicine. The authors call it "one of the most effective cancer prevention interventions developed in the last half-century." And they're not exaggerating. A clean colonoscopy - no adenomas found - essentially hands you a hall pass from colorectal cancer worry for 10, possibly even 20 years. That's a remarkable shield.
But here's where the plot thickens. The editorial accompanies a massive study by Gupta and colleagues that followed nearly 92,000 U.S. veterans aged 75 and older who'd had prior colonoscopies (Gupta et al., 2026). Roughly a quarter had previously had adenomas (those pre-cancerous polyps your gastroenterologist gets excited about removing). The rest were adenoma-free.
The Villain Isn't Who You Think
Ten years later, here's the twist nobody saw coming - except, well, actuaries. Among those with prior adenomas, only 1.1% developed colorectal cancer. Among those without, just 0.7%. Deaths specifically from colorectal cancer? A sliver: 0.5% and 0.4%, respectively.
Meanwhile, the real antagonist had been lurking backstage the whole time. Non-colorectal-cancer mortality - heart disease, stroke, pneumonia, the whole ensemble cast of aging - claimed between 47% and 48% of both groups. For severely frail patients with prior adenomas, that number ballooned to 82%.
Read that again: an older adult with prior polyps was roughly 80 times more likely to die from something other than colon cancer than from colon cancer itself.
The Procedure Isn't Exactly a Spa Day
This math matters because colonoscopy isn't a casual afternoon activity, especially once you're north of 75. The prep alone - drinking a gallon of what can only be described as revenge fluid - gets harder with age. Bowel preparation quality drops in older patients, and completion rates follow (Karajeh et al., 2006). Sedation carries higher risks of blood pressure drops, confusion, and breathing trouble. Perforation risk climbs because aging colons are more fragile and often riddled with diverticulosis. Post-polypectomy bleeding, rare in younger patients, affects up to 3% of those over 75 (Day et al., 2011).
In other words, we're asking people to endure increasing risk from a procedure that's hunting for a threat that's been dramatically outgunned by everything else on the medical roster.
So When Do You Get Off the Train?
The U.S. Preventive Services Task Force already says routine screening should run from age 45 to 75, with ages 76-85 handled on a case-by-case basis (USPSTF, 2021). The editorial from Wang and colleagues reinforces this with a sharp clinical point: for older adults, especially those with comorbidities or frailty, the competing risks of mortality so thoroughly overshadow colorectal cancer risk that continued surveillance colonoscopy may do more harm than good.
This isn't about giving up on people. It's about redirecting medical attention where it actually changes outcomes. A colonoscopy slot taken by an 82-year-old with heart failure and diabetes could go to a 50-year-old who's never been screened - where the intervention genuinely saves lives.
The Real Takeaway
The narrative of cancer screening has always been "more is better, earlier is smarter." And for most of the population, that story holds. But every good story needs a satisfying ending, and for older adults, that ending might be: "You've been screened. You're clear. Now let's focus on what actually threatens you."
The colonoscope is a hero. But even heroes need to know when the mission is complete.
References
-
Wang CP, Shah BJ, Itzkowitz SH. Assessing Colorectal Cancer and Mortality Risk in Older Adults. JAMA. Published April 9, 2026. DOI: 10.1001/jama.2026.2657
-
Gupta S, et al. Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy. JAMA. Published April 9, 2026. DOI: 10.1001/jama.2026.3414
-
US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965-1977. Link
-
Day LW, et al. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc. 2011;74(4):885-896. PMCID: PMC3371336
-
Travis AC, et al. Colon Cancer Screening in the Elderly: When Do We Stop? Curr Treat Options Gastroenterol. 2010;13(1):82-95. PMCID: PMC2917147
-
Kothari ST, et al. Performing Colonoscopy in Elderly and Very Elderly Patients: Risks, Costs and Benefits. World J Gastrointest Endosc. 2014;6(6):220-226. PMCID: PMC4055990
Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.